<unk>  is a short or intermediate acting benzodiazepine that is FDA approved for the treatment of short-term management of insomnia.   Common adverse reactions include somnolence, hypokinesia, dizziness, and ataxia.
Estazolam
Triazolam
Climazolam
Cloxazolam
Midazolam 
Adinazolam
Ketazolam
Quazepam